Cellular senescence and the senescent secretory phenotype in age-related chronic diseases

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 4, 2014, Pages 324-328

  Zhu, Yi ^a   Armstrong, Jacqueline L ^a   Tchkonia, Tamara ^a   Kirkland, James L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Inflammation; Senescence; Senescence Associated secretory phenotype

Indexed keywords

COLLAGENASE 3; GELATINASE A; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN; VASCULOTROPIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN ATROPHY; CELL MIGRATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERTENSION; INFLAMMATION; MICROGLIA; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PHENOTYPE; REVIEW; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; TELOMERE SHORTENING; CELL AGING; CHRONIC DISEASE; PATHOPHYSIOLOGY;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CELL AGING; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INFLAMMATION; NEOPLASMS; OSTEOARTHRITIS; PHENOTYPE;

EID: 84902297367     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000065     Document Type: Review

References (53)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37:614-636.
2. Larsson LG. Oncogene-and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol 2011; 21:367-376.
3. Campisi J, dAdda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-740.
4. Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature 2012; 481:278-286.
5. Hoare M, Narita M. Transmitting senescence to the cell neighbourhood. Nat Cell Biol 2013; 15:887-889.
6. Acosta JC, Banito A, Wuestefeld T, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013; 15:978-990.
7. Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest 2013; 123:966-972.
8. Coppe JP, Patil CK, Rodier F, et al. Senescence-Associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-2868.
9. Kuilman T, Michaloglou C, Vredeveld LC, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019-1031.
10. Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage responseindependent regulator of the senescence-Associated secretory phenotype. EMBO J 2011; 30:1536-1548.
11. Salminen A, Kauppinen A, Kaarniranta K. Emerging role of NF-kappaB signaling in the induction of senescence-Associated secretory phenotype (SASP). Cell Signal 2012; 24:835-845.
12. Salminen A, Kaarniranta K. Control of p53 and NF-kappaB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. Cell Signal 2011; 23:747-752.
13. Hubackova S, Krejcikova K, Bartek J, et al. IL1-and TGFbeta-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine bystander senescence. Aging (Albany NY) 2012; 4:932-951.
14. Wang M, Lakatta EG. The salted artery and angiotensin II signaling: a deadly duo in arterial disease. J Hypertens 2009; 27:19-21.
15. Sikora E, Bielak-Zmijewska A, Mosieniak G. Cellular senescence in ageing, age-related disease and longevity. Curr Vasc Pharmacol 2013. [Epub ahead of print] This article provides a review of senescence in aging and its contibution to aging and age-related diseases.
16. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol 2013; 10:274-283.
17. Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev 2013. [Epub ahead of print]
18. Kunieda T, Minamino T, Nishi J, et al. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2006; 114:953-960.
19. Herbert KE, Mistry Y, Hastings R, et al. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res 2008; 102:201-208.
20. Kroller-Schon S, Jansen T, Schuler A, et al. Peroxisome proliferator-Activated receptor gamma, coactivator 1alpha deletion induces angiotensin II-Associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation. Arterioscler Thromb Vasc Biol 2013; 33:1928-1935.
21. Bidault G, Garcia M, Vantyghem MC, et al. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction. Arterioscler Thromb Vasc Biol 2013; 33:2162-2171.
22. Wang M, Zhang J, Telljohann R, et al. Chronic matrix metalloproteinase inhibition retards age-Associated arterial proinflammation and increase in blood pressure. Hypertension 2012; 60:459-466.
23. Suzuki E, Takahashi M, Oba S, et al. Oncogene-and oxidative stress-induced cellular senescence shows distinct expression patterns of proinflammatory cytokines in vascular endothelial cells. ScientificWorldJournal 2013; 2013:754735.
24. Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9:667-684.
25. Harte AL, da Silva NF, Miller MA, et al. Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus. Exp Diabetes Res 2012; 2012:895185.
26. Markowski DN, Thies HW, Gottlieb A, et al. HMGA2 expression in white adipose tissue linking cellular senescence with diabetes. Genes Nutr 2013; 8:449-456.
27. Mortuza R, Chen S, Feng B, et al. High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One 2013; 8:e54514.
28. Larsen SA, Kassem M, Rattan SI. Glucose metabolite glyoxal induces senescence in telomerase-immortalized human mesenchymal stem cells. Chem Cent J 2012; 6:18.
29. Cao D, Zhang M, Jiang C, et al. Protection of Tanshinone IIA to human peritoneal mesothelial cells (HPMC) through delaying cellular senescence induced by high glucose. Ren Fail 2012; 34:88-94.
30. Hipkiss AR, Cartwright SP, Bromley C, et al. Carnosine: can understanding its actions on energy metabolism and protein homeostasis inform its therapeutic potential? Chem Cent J 2013; 7:38.
31. Enos RT, Davis JM, Velazquez KT, et al. Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters. J Lipid Res 2013; 54:152-163.
32. Daniele G, Guardado Mendoza R, Winnier D, et al. The inflammatory status score including IL-6, TNF-Alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2014; 51:123-131.
33. Sarvas JL, Khaper N, Lees SJ. The IL-6 paradox: context dependent interplay of SOCS3 and AMPK. J Diabetes Metab 2013; Suppl. 13:S13-003.
34. Handa M, Vanegas S, Maddux BA, et al. XOMA 052, an anti-IL-1beta monoclonal antibody, prevents IL-1beta-mediated insulin resistance in 3T3-L1 adipocytes. Obesity (Silver Spring) 2013; 21:306-309.
35. Krasnokutsky S, Attur M, Palmer G, et al. Current concepts in the pathogenesis of osteoarthritis.Osteoarthritis Cartilage 2008; 16 (Suppl 3):S1-S3.
36. Rose J, Soder S, Skhirtladze C, et al. DNA damage, discoordinated gene expression and cellular senescence in osteoarthritic chondrocytes. Osteoarthritis Cartilage 2012; 20:1020-1028.
37. Philipot D, Guerit D, Platano D, et al. p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-Associated matrix remodelling in osteoarthritis. Arthritis Res Ther 2014; 16:R58.
38. So MW, Lee EJ, Lee HS, et al. Protective effects of ginsenoside Rg3 on human osteoarthritic chondrocytes. Mod Rheumatol 2013; 23:104-111.
39. Shen M, Luo Y, Niu Y, et al. 1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via secretion of senescence-Associated inflammatory cytokines. Bone 2013; 55:400-409.
40. Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012; 148:1204-1222.
41. Olivieri F, Rippo MR, Procopio AD, et al. Circulating inflamma-miRs in aging and age-related diseases. Front Genet 2013; 4:121.
42. Shimada IS, LeComte MD, Granger JC, et al. Self-renewal and differentiation of reactive astrocyte-derived neural stem/progenitor cells isolated from the cortical peri-infarct area after stroke. J Neurosci 2012; 32:7926-7940.
43. Verkhratsky A, Sofroniew MV, Messing A, et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012; 131-149.
44. Hewitt G, Jurk D, Marques FD, et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012; 3:708.
45. Bhat R, Crowe EP, Bitto A, et al. Astrocyte senescence as a component of Alzheimers disease. PLoS One 2012; 7:e45069.
46. Varnum MM, Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimers disease brain. Arch Immunol Ther Exp (Warsz) 2012; 60:251-266.
47. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimers disease, role of cytokines. ScientificWorldJournal 2012; 2012:756357.
48. Broussard GJ, Mytar J, Li RC, et al. The role of inflammatory processes in Alzheimers disease. Inflammopharmacology 2012; 20:109-126.
49. Sugama S, Takenouchi T, Cho BP, et al. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm Allergy Drug Targets 2009; 8:277-284.
50. Norden DM, Godbout JP. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 2013; 39:19-34.
51. Yu HM, Zhao YM, Luo XG, et al. Repeated lipopolysaccharide stimulation induces cellular senescence in BV2 cells. Neuroimmunomodulation 2012; 19:131-136.
52. Chinta SJ, Lieu CA, Demaria M, et al. Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinsons disease? J Intern Med 2013; 273:429-436.
53. Kirkland JL. Translating advances from the basic biology of aging into clinical application. Exp Gerontol 2013; 48:1-5.